$150M sweet spot round size
Most of their 9 investments are in rounds between $100M and $226M
2020
Undisclosed raised $226M on September 6, 2023
Investors: M&G plc and Patient Square Capital
Kriya Therapeutics raised $150M on July 26, 2023
Investors: Patient Square Capital
Undisclosed raised $300M on May 1, 2023
Investors: Patient Square Capital
Resolve Biosciences raised $71M on October 24, 2022
Investors: PS Capital Management, Alafi Capital Corp, EDBI Pte Ltd, High-Tech Gründerfonds, NRW.BANK and Patient Square Capital
Alladapt Immunotherapeutics, Inc. raised $119M on June 22, 2022
Investors: Red Tree Venture Capital, Gurnet Point Capital, WestRiver Group and Patient Square Capital
Kriya Therapeutics raised $270M on May 16, 2022
Investors: Narya, Transhuman Capital, Dexcel Pharma, QVT Financial LLP, Foresite Capital, JDRF T1D Fund and Patient Square Capital
Roivant Sciences raised $200M on October 1, 2021
Investors: Suvretta Capital Management LLC, Dainippon Sumitomo Pharma, Palantir Technologies, Viking Global Investors, Eventide Asset Management, RTW Investments, LP and Patient Square Capital
Kriya Therapeutics raised $100M on July 14, 2021
Investors: Narya, Transhuman Capital, QVT Financial LLP, Dexcel Pharma, Foresite Capital, Woodline Partners LP, JDRF T1D Fund and Patient Square Capital
Undisclosed raised $140M on June 17, 2021
Investors: UCL Technology Fund, Reimagined Ventures and Patient Square Capital